Advanced search
Publication Cover
Human Vaccines & Immunotherapeutics Volume 18, 2022 - Issue 1
Submit an article Journal homepage
4,143
Views
8
CrossRef citations to date
0
Altmetric
Meningococcal – Research Paper

Immunogenicity and safety of an investigational quadrivalent meningococcal conjugate vaccine administered as a booster dose in children vaccinated against meningococcal disease 3 years earlier as toddlers: A Phase III, open-label, multi-center study

Franco M. Piazzaa Global Clinical Development, Sanofi Pasteur, Swiftwater, PA, USAView further author information
,
Miia Virtab Vaccine Research Center, Tampere University, Tampere, FinlandView further author information
,
Marita Paassiltac Espoo Vaccine Research Clinic, Tampere University, Tampere, FinlandView further author information
,
Benita Ukkonenb Vaccine Research Center, Tampere University, Tampere, FinlandView further author information
,
Anitta Ahonenb Vaccine Research Center, Tampere University, Tampere, FinlandView further author information
,
Alejandra Esteves-Jaramilloa Global Clinical Development, Sanofi Pasteur, Swiftwater, PA, USAView further author information
,
Aino Forstenb Vaccine Research Center, Tampere University, Tampere, FinlandView further author information
,
Ilkka Seppab Vaccine Research Center, Tampere University, Tampere, FinlandView further author information
,
Jian Dingd Biostatistics and Programming, Clinical Scientific Operations, Sanofi, Beijing, ChinaView further author information
,
David Neveue Global Pharmacovigilance, Sanofi Pasteur, Swiftwater, PA, USAView further author information
,
Emilia Jordanova Global Clinical Development, Sanofi Pasteur, Swiftwater, PA, USAView further author information
&
Mandeep S. Dhingraa Global Clinical Development, Sanofi Pasteur, Swiftwater, PA, USACorrespondence[email protected]
ORCID Iconhttps://orcid.org/0000-0002-2507-7165View further author information
ORCID Icon show all
Pages 1-10 | Received 23 Dec 2020, Accepted 06 Mar 2021, Published online: 04 Jun 2021

Citations (8)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (5)

Silvia Ricci, Chiara Azzari, Emanuele Amodio & Paolo Castiglia. (2023) Immunogenicity and safety of a quadrivalent meningococcal tetanus toxoid-conjugate vaccine (MenACYW-TT): A review of the evidence and expert opinion. Expert Review of Vaccines 22:1, pages 447-456.
Read now
Corwin A. Robertson, Jeffry Jacqmein, Alexandre Selmani, Katherine Galarza & Philipp Oster. (2023) Immunogenicity and safety of a quadrivalent meningococcal conjugate vaccine (MenACYW-TT) administered as a booster to adults aged ≥59 years: A phase III randomized study. Human Vaccines & Immunotherapeutics 19:1.
Read now
Gary S. Marshall, Stephen I. Pelton, Corwin A. Robertson & Philipp Oster. (2022) Immunogenicity and safety of MenACWY-TT, a quadrivalent meningococcal tetanus toxoid conjugate vaccine recently licensed in the United States for individuals ≥2 years of age. Human Vaccines & Immunotherapeutics 18:6.
Read now
Markus Knuf, Mika Rämet, Nina Breinholt Stærke, Isabelle Bertrand-Gerentes, Yaël Thollot, Siham B'Chir, Habiba Arroum & Philipp Oster. (2022) Comparing the meningococcal serogroup C immune response elicited by a tetanus toxoid conjugate quadrivalent meningococcal vaccine (MenACYW-TT) versus a quadrivalent or monovalent C tetanus toxoid conjugate meningococcal vaccine in healthy meningococcal vaccine-naïve toddlers: A randomised, controlled trial. Human Vaccines & Immunotherapeutics 18:5.
Read now
Federico Martinón-Torres, Isabelle Bertrand-Gerentes & Philipp Oster. (2021) A novel vaccine to prevent meningococcal disease beyond the first year of life: an early review of MenACYW-TT. Expert Review of Vaccines 20:9, pages 1123-1146.
Read now

Articles from other publishers (3)

Betzana Zambrano, James Peterson, Carmen Deseda, Katie Julien, Craig A. Spiegel, Clifford Seyler, Michael Simon, Robert Hoki, Marc Anderson, Brad Brabec, Germán Áñez, Jiayuan Shi, Judy Pan, Audrey Hagenbach, Dalia Von Barbier, Kucku Varghese, Emilia Jordanov & Mandeep Singh Dhingra. (2023) Quadrivalent meningococcal tetanus toxoid-conjugate booster vaccination in adolescents and adults: phase III randomized study. Pediatric Research 94:3, pages 1035-1043.
Crossref
Osamu Matsuoka, Mugen Ujiie, Hitoshi Kikuchi, Sachiko Otake, Danaya Chansinghakul, Takahiro Inoue, Kucku Varghese, Nuchra Sirisuphmitr, Tomoyuki Hashiguchi, Betzana Zambrano, Takahiro Nakama, Carina Frago, Emilia Jordanov & Mandeep Singh Dhingra. (2023) Immunogenicity and Safety of a Quadrivalent Meningococcal Tetanus Toxoid-Conjugate Vaccine (MenACYW-TT) in Meningococcal Vaccine-Naïve Participants across a Broad Age Range (2–55 Years) in Japan: a Phase III Randomized Study. Japanese Journal of Infectious Diseases 76:3, pages 174-182.
Crossref
Jessica Huston, Kevin Galicia & Eric F. Egelund. (2021) MenQuadfi (MenACWY-TT): A New Vaccine for Meningococcal Serogroups ACWY. Annals of Pharmacotherapy 56:6, pages 727-735.
Crossref

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.